Tierra raises $11.4 in Series A round for predictive AI protein maker
The US company is part of a burgeoning artificial intelligence (AI) market in early-stage drug development.
The US company is part of a burgeoning artificial intelligence (AI) market in early-stage drug development.
What's Your Reaction?
